CSL shares have dropped 28% amid investor concerns over short-term revenue shortfalls and upcoming challenges like US pharmaceutical tariffs. Despite recent struggles, CSL's long-term growth remains ...

(Reuters) -Australian biotech CSL said on Tuesday it no longer expects to complete the spin-off of its vaccine division in fiscal 2026, citing heightened volatility in the U.S. influenza vaccine ...

CSL faces the prospect of a second strike in two years this week when the board fronts angry investors after a poorly received restructure wiped billions of dollars from the biotechnology giant’s ...

CSL shares are in the green today. Despite short-term challenges and recent volatility, analysts see significant upside for CSL shares. Analysts like Macquarie and Bell Potter believe the shares are ...

The BMW M4 CSL marks a new era of performance and precision. Lighter, sharper, and more focused than the M4 Competition, it’s the most powerful M car ever built for the road. In this in-depth look, we ...

Good morning, ladies and gentlemen. We still have some people registering, but we always start our Board meetings on time at CSL. So today will be no exception. Welcome to CSL's 2025 Annual General ...

The BMW M4 CSL captured on arrival — sharp lines, lightweight focus, and pure M performance. A closer look at one of BMW’s most exclusive and dynamic creations. Experts link widely taken medicine to ...

CSL is trying hard to reset relations with investors. It has modified revenue and earnings guidance. It has ushered in a new chief financial officer. It is promising to simplify a business that ...

Australia's CSL is wielding the axe, cutting its workforce by 15% – around 3,000 positions – while announcing plans to spin its vaccines unit into a standalone company. The decision to demerge the CSL ...

The benchmark ASX 200 index closed 43.10 points lower, or 0.48 per cent down, to 9,012.50, while the broader All Ordinaries gave up 56.10 points or 0.60 per cent to 9,295.80. Australia’s dollar ...

The ASX healthcare sector has felt the fallout of the latest selloff in the sector's largest stock CSL (ASX:CSL) this week after its shares tumbled more than 15% on Tuesday after management trimmed ...